As of Oct 21
| -0.0154 / -2.24%|
The 3 analysts offering 12-month price forecasts for Tonix Pharmaceuticals Holding Corp have a median target of 1.25, with a high estimate of 10.00 and a low estimate of 1.00. The median estimate represents a +85.74% increase from the last price of 0.67.
The current consensus among 3 polled investment analysts is to Hold stock in Tonix Pharmaceuticals Holding Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.